Websites, domains, hosts that links to astrazeneca-us.com

LYNPARZA® (olaparib) is the first and only PARP inhibitor approved in 2 distinct settings: maintenance for recurrent ovarian cancer and following 3 or more lines of prior chemotherapy.

Official patient site. Learn about PULMICORT FLEXHALER a medication for the maintenance treatment of asthma symptoms in adults and children 6 years or older. Find information about the inhaler and side effects and a How to Use FLEXHALER video.

Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

Eosinophilic asthma can have a serious long-term impact on asthma severity and control in your patients. Sign up for updates on eosinophilic asthma from AstraZeneca.

Get your free e-book for breathing tips, exercises, and more, plus receive bonus content personalized to your needs from our added feature BREATHABLE.

BEVESPI AEROSPHERE is a twice-daily long term treatment for adults with COPD.

FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to help reduce A1C levels.

Patient information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.

Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.

Find out more about QTERN® (dapagliflozin and saxagliptin) and how it may help your patients in managing type 2 diabetes.

Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).

Get helpful information about BRCA mutations and testing to see how BRCA genetics can affect your cancer risk.

BYETTA is a non-insulin type 2 diabetes injection medication for adults.

BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long‐term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.

FASENRA™ (benralizumab) is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in adults whose asthma is not controlled with their current asthma medicines.

IRESSA® (gefitinib) is a treatment for patients.

Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.

Help protect against seasonal flu with FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) - the flu vaccine that starts working in the nose.

Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

Official health care professional website for PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg), a maintenance asthma treatment for patients 6 years of age and older.

FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.

Find out more about PD-L1 inhibition, CTLA-4 inhibition, other Immuno-Oncology pathways like OX40 agonism, Anti-CEA BiTE, STAT3 inhibition, and PD-1 inhibition.

Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Learn more about the now-approved FASENRA for add-on treatment of eosinophilic asthma.

Learn about SYMLIN, a prescription medicine for adults with type 1 or type 2 diabetes not adequately controlled on mealtime insulin.

Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.

Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.

Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

BreathABLE from SYMBICORT (budesonide/formoterol fumarate dihydrate) was created to help you control and manage difficulty breathing if you have COPD.

Official patient Web site for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects

Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.

Information about CRESTOR® (rosuvastatin calcium), a prescription cholesterol medicine that helps lower LDL cholesterol when diet and exercise alone are not enough.

Learn about once-weekly BYDUREON, the BYDUREON Pen, and how BYDUREON affected A1C levels and more in multiple clinical trials.

Access 360 provides resources and information to help patients and health care providers gain access to AstraZeneca medicines.

Is your severe asthma e-asthma? Read about e-asthma (eosinophilic asthma) and find out more about severe asthma and eosinophils.

IMFINZI™ (durvalumab) is an immunotherapy used to treat a type of cancer in the bladder and urinary tract called urothelial carcinoma. Learn more about IMFINZI.

Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.

The AZandMe Prescription Savings program is designed to help qualifying patients, including those who receive their medications through participating healthcare facilities. This site will guide you through the AZ&Me application process to see if you are eligible for the program. Find out if you qualify to receive AstraZeneca medicines at no cost.

LYNPARZA®(olaparib) is a type of targeted therapy for ovarian cancer called a PARP inhibitor. LYNPARZA may be used at different stages of ovarian cancer treatment.

12th Annual Gulf Heart Association & 4th Kuwait Cardiac Society Conference

Radiation oncology, radiation therapy, radiotherapy